Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma

NCT03613259 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding expired

Conditions

Stage II Adult Soft Tissue Sarcoma
Stage IIA Adult Soft Tissue Sarcoma
Stage IIB Adult Soft Tissue Sarcoma
Stage IIC Adult Soft Tissue Sarcoma
Stage III Adult Soft Tissue Sarcoma
Stage IV Adult Soft Tissue Sarcoma

Interventions

DRUG: Fluorothymidine F-18
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Positron Emission Tomography

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]